Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (6.671)

21

Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Brunner, H. | Ruperto, N. | Ramanan, A. | +18

22

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease : A subgroup analysis of a global, randomised, controlled Phase 3 trial

enthalten in: Modern rheumatology | 2024

von Kuwana, M. | Takehara, K. | Tanaka, Y. | +4

23

Multiple Sclerosis-Associated Uveitis : A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab

enthalten in: Ocular immunology and inflammation | 2024

von Gil, W. | Lagrib, H. | Olagne, L. | +8

24

Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Yoshida, H. | Magi, M. | Tamai, H. | +7

25

Is there a paradoxical side effect? Is it a case of inefficiency? Peripheral ulcerative keratitis in a patient with rheumatoid arthritis in remission treated with tocilizumab

enthalten in: Turkish journal of physical medicine and rehabilitation | 2024

von Tombak, Y. | Sezer, M. | Bal, A. | +2

26

Tocilizumab in chronic active antibody-mediated rejection : rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

enthalten in: Trials | 2024

von Streichart, L. | Felldin, M. | Ekberg, J. | +10

27

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

enthalten in: Trials | 2024

von Streichart, L. | Felldin, M. | Ekberg, J. | +10

28

Tocilizumab discontinuation after remission achievement in patients with adult-onset Still's disease

enthalten in: Rheumatology (Oxford, England) | 2024

von Tamai, H. | Kondo, Y. | Takeuchi, T. | +1

29

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

30

Tocilizumab Successfully Treating Refractory Hearing Impairment in a Patient With Cogan Syndrome : A Case Report and Review of the Literature

enthalten in: Ear, nose, & throat journal | 2024

von Chen, Y. | Hu, J. | Wu, D. | +2